Where does Jubilant Life Sciences Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Jubilant Life Sciences Limited ranks #48,024 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Jubilant Life Sciences Limited hold?

Jubilant Life Sciences Limited holds 5 US utility patents granted between 2015 and 2019, spanning 10 technology areas.

What is Jubilant Life Sciences Limited's Innovation Score?

Jubilant Life Sciences Limited has an Innovation Score of 29.6 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Jubilant Life Sciences Limited focus on?

Jubilant Life Sciences Limited's top technology area is C07D (Heterocyclic Compounds) with 4 patents, ranking #1,646 of 3,165 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Jubilant Life Sciences Limited's patent grant rate increasing or decreasing?

Jubilant Life Sciences Limited's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Jubilant Life Sciences Limited's patents?

Jubilant Life Sciences Limited's patents average 20.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Jubilant Life Sciences Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jubilant Life Sciences Limited

USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jubilant ranks #48,024 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 10 technology areas.

#48,024
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.6/100): 20.4
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48024 · Foreign Corporation #48,024 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,024/49,997
PHOTO-FINISH Jospak Oy
CPC-FOCUS C07D · 10 areas
INNOV-THIN 29.6/100
CLAIMS-DENSE 20.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jospak Oy (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Jubilant’s 29.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (21%) Velocity 0.0 pts (0%) Breadth 11.2 pts (38%) Claim depth 12.2 pts (41%)

Qualcomm Incorporated · highest

85
Jubilant Life Sciences · this assignee

30
3D Lighting… · lowest

7

What this shows Jubilant's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Jubilant?

Each dot is one of Jubilant’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Jubilant’s own 20.4 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Jubilant vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Jubilant's grants concentrate

Jubilant Life Sciences Limited is a focused PatentsView assignee: 10 CPC subclasses with 80% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2019. By volume, Jubilant sits between Jospak Oy and Junttan Oy.

Jospak Oy

5
Jowat

5
Jowat SE

5
Joytunes

5
Julier Medical

5
Julius Montz

5
Julius Zorn

5
Junttan Oy

5
Jubilant Life Sci… ◀

5

What this shows Jubilant holds 5 patents at rank #48,037, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jubilant

By rank, the assignees closest to #48,037 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Jubilant's primary technology class.

Jubilant's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Jubilant Life Sciences Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	40.0%
2016	2	40.0%
2019	1	20.0%

Which technologies does Jubilant Life Sciences Limited patent most?

C07D - Heterocyclic Compounds 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C07C - Acyclic OR Carbocyclic Compounds 1

Y10T - Technical Subjects Covered BY Former US Classification 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Jubilant Life Sciences Limited's patent record in context - here's where to go next.

Jubilant Life Sciences Limited's lead technology class is C07D (Heterocyclic Compounds), 80% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #48,024 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Jubilant Life Sciences Limited against Jospak Oy, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.